Shijiazhuang Yiling Pharmaceutical (002603.SZ): Withdrawal of the application for clinical trials of "G201-Na Capsules" medication.

Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced that, based on the relevant policies of drug approval and the progress of research projects, the company has decided, after careful consideration, to apply to the National Medical Products Administration (hereinafter referred to as "NMPA") to withdraw the clinical trial application for the drug "G201-Na Capsules" for the indication of "assisted reproduction". Recently, the company received the "Notice of Termination of Drug Registration Application" issued by the NMPA.